SCHEMBL25544765

SCHEMBL25544765

N#Cc1ccc(-c2ccc(N(c3ccc(-c4nc5ccccc5o4)cc3)c3ccc(-c4cccc5c4oc4ccccc45)cc3)cn2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNA7 P36544 1/20 0.36
CHRNA10 Q9GZZ6 1/20 0.36
CHRNA9 Q9UGM1 1/20 0.36
NPC1 O15118 4/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
TP53 P04637 2/20 0.36
HPGD P15428 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HSD17B10 Q99714 2/20 0.36
RAB9A P51151 3/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
ATM Q13315 1/20 0.35
ALOX5 P09917 1/20 0.35
HDAC6 Q9UBN7 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25543239 0.93 NPC1 (0.41) CHRNB4CHRNA3CHRNA7CHRNA10CHRNA9
SCHEMBL25544169 0.92 NPC1 (0.40) CHRNB4CHRNA3CHRNA7CHRNA10CHRNA9
SCHEMBL25544764 0.89 NPC1 (0.44) CHRNB4CHRNA3CHRNA7CHRNA10CHRNA9
SCHEMBL25543237 0.89 NPC1 (0.44) CHRNB4CHRNA3CHRNA7CHRNA10CHRNA9
SCHEMBL25544167 0.88 NPC1 (0.43) CHRNB4CHRNA3CHRNA7CHRNA10CHRNA9
SCHEMBL25543104 0.87 HSD17B10 (0.43) CHRNB4CHRNA3CHRNA7CHRNA10CHRNA9
SCHEMBL25543324 0.86 NPC1 (0.41) CHRNB4CHRNA3CHRNA7CHRNA10CHRNA9
SCHEMBL25543625 0.86 HSD17B10 (0.42) CHRNB4CHRNA3CHRNA7CHRNA10CHRNA9
SCHEMBL25544453 0.85 NPC1 (0.40) CHRNB4CHRNA3CHRNA7CHRNA10CHRNA9
SCHEMBL23328455 0.85 NPC1 (0.48) CHRNB4CHRNA3CHRNA7CHRNA10CHRNA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230301181-A1 TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-09-21 US disclosed
US-20230301181-A1 TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-09-21 US disclosed
EP-4183784-A1 TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME Lapto Co., Ltd. (KR) 2023-05-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230301181-A1 TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME SAT1, FTO, SETDB1 CHRNB4 1431/4885CHRNA3 1581/4885CHRNA7 895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.